Cryo-Cell International Inc logo

Cryo-Cell International Inc

$ 4.89 +0.05 (+1.03%) 10:08 PM EST
On watch
P/E:
32.60
P/B:
0
Market Cap:
$ 41.66M
Enterprise V:
$ 48.15M
Volume:
2.53K
Avg Vol (2M):
7.63K
Also Trade In:
Volume:
2.53K
Market Cap $:
41.66M
PE Ratio:
32.60
Avg Vol (2-Month):
7.63K
Enterprise Value $:
48.15M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Name Current Vs Industry Vs History
Cash-To-Debt 0.31
Equity-to-Asset -0.04
Debt-to-Equity -3.96
Debt-to-EBITDA 2.06
Interest Coverage 2.95
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.25
Distress
Grey
Safe
Beneish M-Score -2.95
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.02
9-Day RSI 48.33
14-Day RSI 46.05
6-1 Month Momentum % -13.03
12-1 Month Momentum % -57.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.47
Quick Ratio 0.43
Cash Ratio 0.13
Days Inventory 36.5
Days Sales Outstanding 64.36
Days Payable 64.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.1

Financials (Next Earnings Date:2023-02-22 Est.)

CCEL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:CCEL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 29.888
EPS (TTM) ($) 0.15
Beta 0.42
Volatility % 43.02
14-Day RSI 46.05
14-Day ATR ($) 0.274266
20-Day SMA ($) 4.90401
12-1 Month Momentum % -57.13
52-Week Range ($) 4.68 - 14
Shares Outstanding (Mil) 8.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cryo-Cell International Inc Filings

Document Form Filing Date
No Filing Data

Cryo-Cell International Inc Analysis

Share your research

Headlines

See More
No news.